KR20070102254A - Process for the preparation of carbapenem intermediates - Google Patents

Process for the preparation of carbapenem intermediates Download PDF

Info

Publication number
KR20070102254A
KR20070102254A KR1020060034162A KR20060034162A KR20070102254A KR 20070102254 A KR20070102254 A KR 20070102254A KR 1020060034162 A KR1020060034162 A KR 1020060034162A KR 20060034162 A KR20060034162 A KR 20060034162A KR 20070102254 A KR20070102254 A KR 20070102254A
Authority
KR
South Korea
Prior art keywords
formula
trimethylsilyl
preparation
compound
diazo
Prior art date
Application number
KR1020060034162A
Other languages
Korean (ko)
Inventor
정윤성
Original Assignee
정윤성
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 정윤성 filed Critical 정윤성
Priority to KR1020060034162A priority Critical patent/KR20070102254A/en
Publication of KR20070102254A publication Critical patent/KR20070102254A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J27/00Catalysts comprising the elements or compounds of halogens, sulfur, selenium, tellurium, phosphorus or nitrogen; Catalysts comprising carbon compounds
    • B01J27/06Halogens; Compounds thereof
    • B01J27/135Halogens; Compounds thereof with titanium, zirconium, hafnium, germanium, tin or lead

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Materials Engineering (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

A process for the preparation of carbapenem intermediates, 4-[3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivatives, is provided to improve preparation yield by using a titanium tetrachloride necessary to prepare the intermediates as different Lewis acid. A process for the preparation of carbapenem intermediates represented by the formula(3) comprises the steps of: reacting compounds represented by the formula(2) in the presence of silylation reagent, base and iodization reagent to form its silyl enolate; and reacting the silyl enolate of compounds represented by the formula(2) with compounds represented by the formula(1) in the presence of a catalyst amount of titanium tetrachloride at 5-10 deg.C for 5-7 hours, wherein R^1 is triethylsilyl, trimethylsilyl or t-butyldimethylsilyl; R^2 is H or CH3; R^3 is benzyl, allyl, C1-4 alkyl or p-nitrobenzyl. The silylation reagent is trimethylsilyl chloride, trimethylsilyl bromide or trimethylsilyl iodide, the base is triethylamine or pyridine and the iodization reagent is KI, NaI or I2.

Description

카바페넴 중간체의 제조방법{Process for the preparation of carbapenem intermediates} Process for the preparation of carbapenem intermediates

본 발명은 카바페넴계 항생제의 제조 중간체의 신규 제조방법에 관한 것으로, 보다 구체적으로는 4-[3-카르복시-3-디아조-2-옥소프로필]아제티딘-2-온 유도체의 제조방법에 관한 것이다. The present invention relates to a novel process for preparing intermediates for the preparation of carbapenem antibiotics, and more particularly to a process for preparing 4- [3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivatives. It is about.

카바페넴 항생제는 광범위한 병원균에 대하여 우수한 항균 작용을 나타내며, 생체 내에서의 안정성도 우수하기 때문에 가장 주목 받고 있는 항생제 중 하나다. 이러한 카바페넴은 하기 화학식 5로서 나타낼 수 있으며, 구체적으로 하기 치환기 R2 및 티올기의 치환기에 따라 파니페넴, 이미페넴, 메로페넴, 티에나마이신 등으로 명명된다.Carbapenem antibiotics are one of the most attracting antibiotics because they show excellent antibacterial activity against a wide range of pathogens and their stability in vivo. Such carbapenems may be represented by the following Chemical Formula 5, specifically named as panipenem, imipenem, meropenem, thienamycin, and the like according to substituents of the following substituents R 2 and thiol groups.

Figure 112006026139517-PAT00004
Figure 112006026139517-PAT00004

US 4,350,631에 따르면, 이러한 카바페넴 항생제는 하기 화학식 4의 화합물을 중간체로 하여 제조될 수 있으며, 하기 화학식 4의 카바페넴의 합성 중간체는 하기 화학식 3의 4-[3-카르복시-3-디아조-2-옥소프로필]아제티딘-2-온 유도체로부터 제조될 수 있다. According to US Pat. No. 4,350,631, such carbapenem antibiotics can be prepared using intermediates of the compounds of formula (4), wherein the synthetic intermediate of carbapenems of formula (4) is 4- [3-carboxy-3-diazo- It can be prepared from 2-oxopropyl] azetidin-2-one derivative.

Figure 112006026139517-PAT00005
Figure 112006026139517-PAT00005

Figure 112006026139517-PAT00006
Figure 112006026139517-PAT00006

상기 화학식에서, R2는 H 또는 CH3 이고, R3는 벤질, 알릴, C1-4 알킬, 또는 p-니트로벤질이다. In the above formula, R 2 is H or CH 3 and R 3 is benzyl, allyl, C 1-4 alkyl, or p-nitrobenzyl.

구체적으로는, 상기 화학식 3의 화합물 및 촉매량의 로듐아세테이트 중합체 {Rh2(OAc)4}를 메틸아세테이트에 용해하고 약 1-3 시간동안 환류한 다음 농축하고 비극성 용매 하에서 결정화 함으로써 상기 화학식 4의 화합물을 제조할 수 있다. Specifically, the compound of Chemical Formula 3 by dissolving the compound of Chemical Formula 3 and the catalytic amount of rhodium acetate polymer {Rh 2 (OAc) 4 } in methyl acetate, refluxing for about 1-3 hours, then concentrating and crystallizing under a non-polar solvent Can be prepared.

상기 화학식 3의 4-[3-카르복시-3-디아조-2-옥소프로필]아제티딘-2-온 유도체를 제조하기 위한 여러가지 방법이 공지되어 있는데, 그 중 하나가 미국 특허 0078026에 개시되어 있다. 그 방법에 따르면, 상기 화학식 3의 화합물은 하기 반응식 2와 같이 4-아세톡시아제티디논 유도체(1a)를 루이스산의 존재 하에서 트리메틸실릴에놀에테르 유도체(2a)와 반응시킴으로써 제조한다. Various methods are known for preparing the 4- [3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivative of Formula 3, one of which is disclosed in US Patent 0078026. . According to the method, the compound of Formula 3 is prepared by reacting 4-acetoxyazetidinone derivative (1a) with trimethylsilylenolether derivative (2a) in the presence of Lewis acid as shown in Scheme 2 below.

Figure 112006026139517-PAT00007
Figure 112006026139517-PAT00007

상기 화학식에서, R1은 t-부틸디메틸실릴이며, R2는 H 또는 CH3 이고, R3는 벤질, 알릴, C1-4 알킬, 또는 p-니트로벤질이다. In the above formula, R 1 is t-butyldimethylsilyl, R 2 is H or CH 3 , and R 3 is benzyl, allyl, C 1-4 alkyl, or p-nitrobenzyl.

그러나, 이러한 제조방법에서는 트리메틸실릴에놀에테르 유도체(2a)의 복잡한 제조방법을 별도로 수행하여야 한다. 이러한 제조방법의 단점을 극복하기 위해, 미국 특허 4,841,042에서는 루이스산 및 실릴화제로서 동시에 작용할 수 있는 루이스산을 도입하였으며, 구체적으로는 트리메틸실릴트리플로로 메탄술포네이트를 이용하였다. However, in this preparation method, a complicated preparation method of the trimethylsilylenol ether derivative (2a) must be performed separately. In order to overcome the drawbacks of this preparation method, US Pat. No. 4,841,042 introduced Lewis acid and Lewis acid, which can act simultaneously as silylating agents, specifically methanesulfonate as trimethylsilyltrifluoro.

그러나, 상기 두 가지 제조방법에서는 생성된 화학식 3의 화합물의 수율이 약 80% 이하에 머물렀다. However, in the two preparation methods, the yield of the produced compound of formula 3 remained below about 80%.

이에 본 발명자들은 카바페넴계 항생제의 제조 중간체인 화학식 3의 4-[3-카르복시-3-디아조-2-옥소프로필]아제티딘-2-온 유도체를 보다 높은 수율로서 제조할 수 있는 방법에 대해 연구한 결과, 화학식 3의 중간체의 제조에 사용되는 루이스산으로서 특히 사염화티타늄을 촉매량 사용하여 제조할 경우 생성되는 화학식 3의 화합물의 수율이 현저히 높아질 수 있다는 것을 발견하여 본 발명을 완성하게 되었다. Therefore, the inventors of the present invention provide a method for preparing a 4- [3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivative of Formula 3, which is an intermediate for preparing a carbapenem antibiotic, in a higher yield. As a result of the study, the present inventors have found that the yield of the compound of formula 3 can be remarkably increased when a Lewis acid used in the preparation of the intermediate of formula 3 is prepared using a catalytic amount of titanium tetrachloride.

따라서, 본 발명은 카바페넴계 항생제의 제조 중간체인 4-[3-카르복시-3-디아조-2-옥소프로필]아제티딘-2-온 유도체를 보다 효율적으로 제조하는 방법을 제공하는 것을 목적으로 한다. Accordingly, an object of the present invention is to provide a method for more efficiently preparing a 4- [3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivative which is an intermediate for preparing a carbapenem antibiotic. do.

상기 목적을 달성하기 위해, 본 발명은In order to achieve the above object, the present invention

하기 화학식 2의 화합물을 실릴화제, 염기 및 요드화제의 존재 하에서 화학식 2의 화합물의 실릴에놀레이트를 형성시킨 다음 촉매량의 사염화티타늄의 존재 하에서 하기 화학식 1의 화합물과 반응시키는 단계를 포함하는 하기 화학식 3의 화합물의 제조방법을 제공한다:To form a silylenolate of a compound of formula (2) in the presence of a silylating agent, a base and an iodide, and then reacting it with a compound of formula (1) in the presence of a catalytic amount of titanium tetrachloride Provided is a process for preparing the compound of 3:

Figure 112006026139517-PAT00008
Figure 112006026139517-PAT00008

Figure 112006026139517-PAT00009
Figure 112006026139517-PAT00009

[화학식 3][Formula 3]

Figure 112006026139517-PAT00010
Figure 112006026139517-PAT00010

상기 화학식에서, In the above formula,

R1은 트리에틸실릴, 트리메틸실릴, 또는 t-부틸디메틸실릴이고,R 1 is triethylsilyl, trimethylsilyl, or t-butyldimethylsilyl,

R2는 H 또는 CH3 이고, R 2 is H or CH 3 ,

R3는 벤질, 알릴, C1-4 알킬, 또는 p-니트로벤질이다. R 3 is benzyl, allyl, C 1-4 alkyl, or p-nitrobenzyl.

상기에서 실릴화제로는 트리메틸실릴클로라이드, 트리메틸실릴브로마이드 또는 트리메틸실릴요오다이드가 이용될 수 있으나, 이에 한정되는 것은 아니다. As the silylating agent, trimethylsilyl chloride, trimethylsilyl bromide or trimethylsilyl iodide may be used, but is not limited thereto.

상기 염기로는 트리에틸아민, 트리부틸아민 또는 피리딘 등의 3급아민이 이용될 수 있으나, 이에 한정되는 것은 아니다. The base may be a tertiary amine such as triethylamine, tributylamine or pyridine, but is not limited thereto.

상기 요오드화제는 KI, NaI, 및 I2로 구성된 그룹에서 선택된 것이 사용될 수 있으나, 이에 한정되는 것은 아니다. The iodide may be selected from the group consisting of KI, NaI, and I 2 , but is not limited thereto.

상기 반응은 비양성자성 용매 중에서 수행할 수 있으며, 그러한 비양성자성 용매는 테트라하이드로퓨란, 아세톤, 디메틸포름아미드, 및 아세토니트릴로 구성된 그룹 중에서 선택될 수 있으나, 이에 한정되는 것은 아니다.The reaction may be carried out in an aprotic solvent, and such an aprotic solvent may be selected from the group consisting of tetrahydrofuran, acetone, dimethylformamide, and acetonitrile, but is not limited thereto.

상기 반응은 바람직하게는 5 내지 10 ℃에서 5 내지 7 시간동안 수행할 수 있다. The reaction may be preferably performed at 5 to 10 ° C. for 5 to 7 hours.

이하, 본 발명을 보다 상세하게 설명한다. Hereinafter, the present invention will be described in more detail.

본 발명은 종래의 카바페넴계 항생제의 제조 중간체로서 사용된 4-[3-카르복시-3-디아조-2-옥소프로필]아제티딘-2-온 유도체를 보다 높은 수율로 제조할 수 있 는 방법을 연구한 결과, 그 중간체의 제조시 필수적으로 사용되는 루이스산으로서 특히 사염화티타늄을 촉매량 사용하는 경우 종래에 구체적으로 사용된 다른 루이스산에 비해 생성물의 수율이 현저히 높아진다는 것을 발견하여 완성된 것이다. The present invention provides a method for producing 4- [3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivatives used as intermediates for the preparation of conventional carbapenem antibiotics in higher yield. As a result of the study, it was found that the yield of the product is significantly higher than that of other Lewis acids specifically used in the past when catalytic amount of titanium tetrachloride is used as the Lewis acid which is essentially used in the preparation of the intermediate.

따라서, 본 발명이 제공하는 화학식 3의 4-[3-카르복시-3-디아조-2-옥소 프로필]아제티딘-2-온 유도체의 제조방법은 하기 반응식 1과 같이 나타낼 수 있다. Therefore, the preparation method of the 4- [3-carboxy-3-diazo-2-oxopropyl] azetidin-2-one derivative of the general formula (3) provided by the present invention may be represented as in Scheme 1 below.

Figure 112006026139517-PAT00011
Figure 112006026139517-PAT00011

상기 반응식 1에서, In Scheme 1,

R1은 트리에틸실릴, 트리메틸실릴, 또는 t-부틸디메틸실릴이고,R 1 is triethylsilyl, trimethylsilyl, or t-butyldimethylsilyl,

R2는 H 또는 CH3 이고, R 2 is H or CH 3 ,

R3는 벤질, 알릴, C1-4 알킬, 또는 p-니트로벤질이다.R 3 is benzyl, allyl, C 1-4 alkyl, or p-nitrobenzyl.

상기 반응은 비양성자성 용매에 실릴화제와 화학식 2의 화합물, 그리고 염기인 3급아민을 가해 화학식 2의 화합물의 용액을 생성시킨 다음, 여기에 화학식 1의 4-아세톡시 아제티디논 유도체를 녹인 용액을 가하고, 루이스산인 사염화티타늄을 촉매량 부가함으로써 수행될 수 있다.In the reaction, a silylating agent, a compound of formula (2), and a tertiary amine, which is a base, are added to an aprotic solvent to produce a solution of the compound of formula (2), and then the 4-acetoxy azetidinone derivative (1) is dissolved therein. It can be performed by adding a solution and adding catalytic amount of titanium tetrachloride which is a Lewis acid.

상기 비양성자성 용매로는 상기 반응을 저해하지 않는 것이기만 하면 어떠한 용매도 가능하며, 예를 들어 테트라하이드로퓨란, 아세톤, 디메틸포름아미드, 및 아세토니트릴로 구성된 그룹에서 선택될 수 있다. The aprotic solvent may be any solvent as long as it does not inhibit the reaction, and may be selected from the group consisting of tetrahydrofuran, acetone, dimethylformamide, and acetonitrile.

상기 화학식 2의 화합물의 용액에서 화학식 2의 화합물은 실릴화제와 염기에 의해 화학식 2의 화합물의 실릴에놀레이트로 변환될 수 있다. 상기 실릴화제는 염기에 의해 생성되는 화학식 2의 화합물의 실릴에놀레이트를 안정화시켜 화학식 2의 반응성을 안정적으로 유지시킬 수 있다. 이러한 실릴화제로는 트리메틸실릴 트리플로로메탄술폰네이트, 트리메틸실릴 클로라이드, 또는 트리메틸실릴 브로마이드, 또는 트리메틸실릴 요오다이드 등이 사용될 수 있다. 상기 염기로는 트리에틸아민, 트리부틸아민 또는 피리딘 등의 3급 아민이 이용될 수 있으나, 이에 한정되는 것은 아니다. In the solution of the compound of Formula 2, the compound of Formula 2 may be converted to the silylenolate of the compound of Formula 2 by a silylating agent and a base. The silylating agent may stabilize the silylenolate of the compound of Formula 2 produced by the base to stably maintain the reactivity of Formula 2. As such silylating agent, trimethylsilyl trifluoromethanesulfonate, trimethylsilyl chloride, or trimethylsilyl bromide, trimethylsilyl iodide and the like can be used. The base may be a tertiary amine such as triethylamine, tributylamine or pyridine, but is not limited thereto.

상기에서 요오드화제는 화학식 2의 화합물을 화학식 1의 4-아세톡시 아제티디논 유도체와의 반응성이 증가되도록 하기 위한 것으로서, 화학식 2의 화합물을 실릴에놀레이트 형으로의 전환시키는 것을 가능하게 한다. 이러한 요오드화제는 KI, NaI, 및 I2로 구성된 그룹에서 선택될 수 있으나, 실릴에놀레이트 형성을 가능 하게 하고 다른 불리한 반응을 일으키지 않는다면 어떠한 요오드화제도 사용 가능하다. The iodinating agent is to increase the reactivity of the compound of formula (2) with the 4-acetoxy azetidinone derivative of formula (1), it is possible to convert the compound of formula (2) to the silyl enolate type. Such iodinating agents may be selected from the group consisting of KI, NaI, and I 2 , but any iodinating agent may be used so long as it enables silylenolate formation and does not cause other adverse reactions.

상기 화학식 1의 4-아세톡시 아제티디논 유도체를 녹인 용액의 제조에 사용되는 용매는 디클로로메탄, 테트라하이드로퓨란, 아세톤, 디메틸포름아미드, 또는 아세토니트릴 등이 사용될 수 있으며, 바람직하게는 디클로로메탄 또는 아세토니트릴이 사용될 수 있다. Dichloromethane, tetrahydrofuran, acetone, dimethylformamide, or acetonitrile may be used as the solvent used in the preparation of the solution of 4-acetoxy azetidinone derivative of Chemical Formula 1, preferably dichloromethane or Acetonitrile can be used.

상기 화학식 2의 화합물의 용액에 화학식 1의 화합물의 용액을 가한 후 루이스산으로서 사염화티타늄을 촉매량 부가하고 반응을 진행시킨다. 반응은 3℃ 내지 약 25℃에서 3 내지 10시간 동안 수행할 수 있으며, 바람직하게는 약 5 내지 10 ℃에서 5 내지 7 시간동안 수행한다. After adding a solution of the compound of Formula 1 to the solution of the compound of Formula 2, a catalytic amount of titanium tetrachloride is added as Lewis acid, and the reaction proceeds. The reaction may be performed at 3 ° C. to about 25 ° C. for 3 to 10 hours, preferably at about 5 to 10 ° C. for 5 to 7 hours.

상기 화학식 1의 4-아세톡시 아제티디논 유도체는 공지되어 있으며, 문헌에 공지되어 있는 방법에 의해 제조될 수 있다(German Offenlegungsschrift No. 19 06 401; A. Oida et al., Chem. Pharm. Bull. 29, 2899 (1981), M. Shiozaki et al., Tetrahedron 39, 2399(1983), M. Shiozaki et al., Tetrahedron 39, 2399 (1983); M. Shiozaki et al. Tetrahedron 40, 1795 (1984), W.J. Leanza et al., Tetrahedron 39, 2505 (1983), T. Kametani et al., J. Chem. Soc. Perkin I 1981, 2228; J. L. Roberts et al., Synthetic Communications 13, 797 (1983)). 4-acetoxy azetidinone derivatives of Formula 1 are known and can be prepared by methods known in the literature (German Offenlegungsschrift No. 19 06 401; A. Oida et al., Chem. Pharm. Bull 29, 2899 (1981), M. Shiozaki et al., Tetrahedron 39, 2399 (1983), M. Shiozaki et al., Tetrahedron 39, 2399 (1983); M. Shiozaki et al. Tetrahedron 40, 1795 (1984 ), WJ Leanza et al., Tetrahedron 39, 2505 (1983), T. Kametani et al., J. Chem. Soc.Perkin I 1981, 2228; JL Roberts et al., Synthetic Communications 13, 797 (1983)) .

상기 화학식 2의 화합물은 공지되어 있으며, 문헌에 공지되어 있는 방법에 의해 제조될 수 있다(S. Julia et al., Compt. Rend. Acad. Sci. Paris, Section C 246, 1890 (1967), 유럽특허 52 299, R M. Kellogg et al., J. C. S. Chem. Comm. (1977) 932). Compounds of Formula 2 are known and can be prepared by methods known in the literature (S. Julia et al., Compt. Rend. Acad. Sci. Paris, Section C 246, 1890 (1967), Europe Patent 52 299, R M. Kellogg et al., JCS Chem. Comm. (1977) 932.

이하, 본 발명을 실시예를 통하여 더욱 상세히 설명한다. 그러나, 이들 실시예는 본 발명을 예시하기 위한 것이며, 본 발명이 이들 실시예에 의해 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to Examples. However, these examples are for illustrating the present invention, and the present invention is not limited by these examples.

실시예 1Example 1

(3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온(3)의 제조(3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitrobenzyloxycarbonylcarbonyl-3-diazo-2-oxopropyl) azetidin-2-one (3) Manufacture

p-니트로벤질 2-디아조-3-옥소부타노에이트 11.9g, KI 15g, 및 트리에틸아민 5.5g을 아세토니트릴 50 mL에 용해하고, 트리메틸실릴 클로라이드 5 g을 적가하였다. 여기에, (3R,4R)-4-아세톡시-3-[(1R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온11.9 g of p-nitrobenzyl 2-diazo-3-oxobutanoate, 15 g of KI, and 5.5 g of triethylamine were dissolved in 50 mL of acetonitrile, and 5 g of trimethylsilyl chloride was added dropwise. Here, (3R, 4R) -4-acetoxy-3-[(1R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one

(일본 Kaneka 제조) 10g을 디클로로메탄 50 mL에 녹여서 가했다. 그 용액에 사염화티타늄 2.5 g을 가한 후 10℃에서 6시간 동안 교반하였다. 10 g (manufactured by Kaneka, Japan) was dissolved in 50 mL of dichloromethane and added. 2.5 g of titanium tetrachloride was added to the solution, followed by stirring at 10 ° C. for 6 hours.

상기 반응액에 10% 중조액을 투입하고 디클로로메탄 150mL로 희석하고, 포화 소금물 50mL 및 증류수 50 mL로 세척한 다음, 유기용매 층을 분리 하고 여과한 후 감압농축 하였다.10% sodium bicarbonate was added to the reaction solution, diluted with 150 mL of dichloromethane, washed with 50 mL of saturated brine, and 50 mL of distilled water. The organic solvent layer was separated, filtered and concentrated under reduced pressure.

잔사를 메탄올 100mL에 용해시키고 15% HCl 15 mL를 실온에서 30 분간 적가한 후 5 시간 동안 교반하였다. 반응이 완결된 후 10% 중조액으로 중화하고 물 200mL를 서서히 투입하여 결정을 석출시킨 다음 수득율을 높이기 위해 10시간 더 실온에서 교반한다. The residue was dissolved in 100 mL of methanol and 15 mL of 15% HCl was added dropwise at room temperature for 30 minutes, followed by stirring for 5 hours. After the reaction was completed, neutralized with a 10% sodium bicarbonate solution, 200 mL of water was slowly added to precipitate crystals, and then stirred at room temperature for 10 hours to increase the yield.

결정이 완전히 석출된 다음 여과하여 감압 건조하면 목적화합물인 (3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온 화합물이 14.1g 수득된다(수율: 91.3%).After the crystals were completely precipitated, filtered and dried under reduced pressure, the target compound was (3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitrobenzyloxycarbonylcarbonyl-3-diazo- 14.1 g of 2-oxopropyl) azetidin-2-one compound are obtained (yield: 91.3%).

비교예 1Comparative Example 1

(3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온의 제조Preparation of (3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitrobenzyloxycarbonylcarbonyl-3-diazo-2-oxopropyl) azetidin-2-one

p-니트로벤질 2-디아조-3-옥소부타노에이트 11.9g, KI 15g, 및 트리에틸아민 5.5g을 아세토니트릴 50 mL에 용해하고, 트리메틸실릴 클로라이드 5 g을 적가하였다. 여기에, (3R,4R)-4-아세톡시-3-[(1R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온 (일본 Kaneka 제조) 10g을 디클로로메탄 50 mL에 녹여서 가했다. 그 용액에 염화아연(ZnCl2) 7.1 g을 가한 후 실온에서 6시간 동안 교반하였다. 11.9 g of p-nitrobenzyl 2-diazo-3-oxobutanoate, 15 g of KI, and 5.5 g of triethylamine were dissolved in 50 mL of acetonitrile, and 5 g of trimethylsilyl chloride was added dropwise. 10 g of (3R, 4R) -4-acetoxy-3-[(1R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one (manufactured by Kaneka, Japan) was dissolved in 50 mL of dichloromethane. Added. 7.1 g of zinc chloride (ZnCl 2) was added to the solution, followed by stirring at room temperature for 6 hours.

상기 반응액을 염화나트륨 20% 수용액 50ml로 세척하고, 50 mL의 증류수로 세척한 다음, 디클로로메탄 100mL를 가하여 층 분리 하고 여과한 후 감압농축 하였다.The reaction solution was washed with 50 ml of sodium chloride 20% aqueous solution, washed with 50 mL of distilled water, and then, 100 mL of dichloromethane was added, the layers were separated, filtered, and concentrated under reduced pressure.

잔사를 메탄올 100mL에 용해시키고 15% HCl 15 mL를 실온에서 30 분간 적가한 후 5 시간 동안 교반하였다. 반응이 완결된 후 10% 중조액으로 중화하고 물 200mL를 서서히 투입하여 결정을 석출시킨 다음 수득율을 높이기 위해 10시간 더 실온에서 교반한다. The residue was dissolved in 100 mL of methanol and 15 mL of 15% HCl was added dropwise at room temperature for 30 minutes, followed by stirring for 5 hours. After the reaction was completed, neutralized with a 10% sodium bicarbonate solution, 200 mL of water was slowly added to precipitate crystals, and then stirred at room temperature for 10 hours to increase the yield.

결정이 완전히 석출된 다음 여과하여 감압 건조하면 목적화합물인 (3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온 화합물이 11.5g 수득된다(수율: 74.5%).After the crystals were completely precipitated, filtered and dried under reduced pressure, the target compound was (3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitrobenzyloxycarbonylcarbonyl-3-diazo- 11.5 g of 2-oxopropyl) azetidin-2-one compound are obtained (yield: 74.5%).

비교예 2Comparative Example 2

(3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온의 제조Preparation of (3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitrobenzyloxycarbonylcarbonyl-3-diazo-2-oxopropyl) azetidin-2-one

p-니트로벤질 2-디아조-3-옥소부타노에이트 12 g, KI 15g, 및 트리에틸아민 5.5g을 아세토니트릴 50 mL에 용해하고, 트리메틸실릴 클로라이드 5 g을 적가하였다. 여기에, (3R,4R)-4-아세톡시-3-[(1R)-1-t-부틸디메틸실릴옥시에틸]아제티딘-2-온(일본 Kaneka 제조) 10g을 디클로로메탄 50 mL에 녹여서 가했다. 그 용액에 트리메틸실릴 트리플루오로메탄술포네이트(TMSOTf) 11.1 g을 가한 후 0℃에서 10시간 동안 교반하였다. 12 g of p-nitrobenzyl 2-diazo-3-oxobutanoate, 15 g of KI, and 5.5 g of triethylamine were dissolved in 50 mL of acetonitrile, and 5 g of trimethylsilyl chloride was added dropwise. Here, 10 g of (3R, 4R) -4-acetoxy-3-[(1R) -1-t-butyldimethylsilyloxyethyl] azetidin-2-one (manufactured by Kaneka, Japan) was dissolved in 50 mL of dichloromethane. Added. 11.1 g of trimethylsilyl trifluoromethanesulfonate (TMSOTf) was added to the solution, followed by stirring at 0 ° C for 10 hours.

상기 반응액을 염화나트륨 20% 수용액 50ml로 세척하고, 50 mL의 증류수로 세척한 다음, 디클로로메탄 100mL를 가하여 층분리 하고 여과한 후 감압농축 하였다.The reaction solution was washed with 50 ml of sodium chloride 20% aqueous solution, washed with 50 mL of distilled water, and then, separated by layering with 100 mL of dichloromethane, filtered, and concentrated under reduced pressure.

잔사를 메탄올 100mL에 용해시키고 15% HCl 15 mL를 실온에서 30 분간 적가한 후 5 시간 동안 교반하였다. 반응이 완결된 후 10% 중조액으로 중화하고 물 200mL를 서서히 투입하여 결정을 석출시킨 다음 수득율을 높이기 위해 10시간 더 실온에서 교반한다. The residue was dissolved in 100 mL of methanol and 15 mL of 15% HCl was added dropwise at room temperature for 30 minutes, followed by stirring for 5 hours. After the reaction was completed, neutralized with a 10% sodium bicarbonate solution, 200 mL of water was slowly added to precipitate crystals, and then stirred at room temperature for 10 hours to increase the yield.

결정이 완전히 석출된 다음 여과하여 감압 건조하면 목적화합물인 (3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온 화합물이 12.6g 수득된다(수율: 81.7%).After the crystals were completely precipitated, filtered and dried under reduced pressure, the target compound was (3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitrobenzyloxycarbonylcarbonyl-3-diazo- 12.6 g of 2-oxopropyl) azetidin-2-one compound are obtained (yield: 81.7%).

상기 실시예 및 비교예와 같이 (3S,4R)-3-(1-히드록시에틸)-4-(3-p-니트로 벤질옥시카보닐카보닐-3-디아조-2-옥소프로필)아제티딘-2-온의 제조방법에 나타난 수율에서 확인할 수 있듯이, 종래의 제조방법에 사용된 염화아연 또는 트리메틸실릴 트리플로로메탄술포네이트 등과 같은 루이스산들을 이용하여 제조할 경우에는 약 80% 이하의 수율을 나타내었으나, 본원발명에서는 루이스산으로서 사염화티타늄을 촉매량 이용하여 90%가 넘는 수율로 화학식 3의 화합물을 획득하였다. 이러한 결과로부터 본원발명은 종래에 구체적으로 사용되어 왔던 루이스산과는 다른 루이스산을 선택함으로써 현저하게 높은 수율로 카바페넴 중간체를 제조할 수 있다는 것을 알 수 있다. (3S, 4R) -3- (1-hydroxyethyl) -4- (3-p-nitro benzyloxycarbonylcarbonyl-3-diazo-2-oxopropyl) ase as in the above Examples and Comparative Examples As can be seen from the yield shown in the preparation method of thidin-2-one, when prepared using Lewis acids such as zinc chloride or trimethylsilyl trilomethanesulfonate used in the conventional manufacturing method, the Although yields were shown, in the present invention, the compound of formula 3 was obtained in a yield of more than 90% by using a catalytic amount of titanium tetrachloride as Lewis acid. From these results, it can be seen that the present invention can prepare carbapenem intermediates with remarkably high yield by selecting a Lewis acid different from the Lewis acid which has been used specifically in the prior art.

앞서 설명한 바와 같이, 본 발명은 촉매량의 사염화티타늄을 이용한 카바페넴 중간체 제조방법으로서 종래에 사용된 다른 루이스산을 이용한 방법에 비해 현저히 높은 수율로 카바페넴 중간체를 제조할 수 있다. As described above, the present invention can produce the carbapenem intermediate in a significantly higher yield as a method for preparing a carbapenem intermediate using a catalytic amount of titanium tetrachloride.

Claims (6)

하기 화학식 2의 화합물을 실릴화제, 염기 및 요드화제의 존재 하에서 화학식 2의 화합물의 실릴에놀레이트를 형성시킨 다음 촉매량의 사염화티타늄의 존재 하에서 하기 화학식 1의 화합물과 반응시키는 단계를 포함하는 하기 화학식 3의 화합물의 제조방법:To form a silylenolate of a compound of formula (2) in the presence of a silylating agent, a base and an iodide, and then reacting it with a compound of formula (1) in the presence of a catalytic amount of titanium tetrachloride Preparation of the compound of 3: [화학식 1][Formula 1]
Figure 112006026139517-PAT00012
Figure 112006026139517-PAT00012
[화학식 2][Formula 2]
Figure 112006026139517-PAT00013
Figure 112006026139517-PAT00013
[화학식 3][Formula 3]
Figure 112006026139517-PAT00014
Figure 112006026139517-PAT00014
상기 화학식에서, In the above formula, R1은 트리에틸실릴, 트리메틸실릴, 또는 t-부틸디메틸실릴이고,R 1 is triethylsilyl, trimethylsilyl, or t-butyldimethylsilyl, R2는 H 또는 CH3 이고, R 2 is H or CH 3 , R3는 벤질, 알릴, C1-4 알킬, 또는 p-니트로벤질이다. R 3 is benzyl, allyl, C 1-4 alkyl, or p-nitrobenzyl.
제 1 항에 있어서, 상기 실릴화제는 트리메틸실릴 클로라이드, 트리메틸실릴 브로마이드, 또는 트리메틸실릴 요오다이드인 것을 특징으로 하는 방법.The method of claim 1 wherein the silylating agent is trimethylsilyl chloride, trimethylsilyl bromide, or trimethylsilyl iodide. 제 1 항에 있어서, 상기 염기는 트리에틸아민 또는 피리딘인 것을 특징으로 하는 방법The method of claim 1 wherein the base is triethylamine or pyridine. 제 1 항에 있어서, 상기 요오드화제는 KI, NaI, 및 I2로 구성된 그룹에서 선택되는 것을 특징으로 하는 방법. The method of claim 1 wherein the iodide agent is selected from the group consisting of KI, NaI, and I 2 . 제 1 항에 있어서, 상기 반응은 디클로로메탄, 테트라하이드로퓨란, 아세톤, 디메틸포름아미드, 아세토니트릴, 또는 이들의 조합으로 구성된 그룹에서 선택된 용매 중에서 수행하는 것을 특징으로 하는 방법.The method of claim 1, wherein the reaction is performed in a solvent selected from the group consisting of dichloromethane, tetrahydrofuran, acetone, dimethylformamide, acetonitrile, or a combination thereof. 제 1 항에 있어서, 상기 반응은 5 내지 10 ℃에서 5 내지 7 시간동안 수행하는 것을 특징으로 하는 방법.The method of claim 1, wherein the reaction is performed at 5 to 10 ° C. for 5 to 7 hours.
KR1020060034162A 2006-04-14 2006-04-14 Process for the preparation of carbapenem intermediates KR20070102254A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020060034162A KR20070102254A (en) 2006-04-14 2006-04-14 Process for the preparation of carbapenem intermediates

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020060034162A KR20070102254A (en) 2006-04-14 2006-04-14 Process for the preparation of carbapenem intermediates

Publications (1)

Publication Number Publication Date
KR20070102254A true KR20070102254A (en) 2007-10-18

Family

ID=38817298

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020060034162A KR20070102254A (en) 2006-04-14 2006-04-14 Process for the preparation of carbapenem intermediates

Country Status (1)

Country Link
KR (1) KR20070102254A (en)

Similar Documents

Publication Publication Date Title
DK160877B (en) PROCEDURE FOR PREPARING 2-PENEM COMPOUNDS
JPH037675B2 (en)
JPH0557980B2 (en)
EP0110280B1 (en) Process for the production of penem compounds
JP2011504495A (en) 2-Arylmethylazetidine-carbapenem-3-carboxylic acid ester derivative or salt thereof, production method thereof and pharmaceutical composition containing the same
JPS6117586A (en) Manufacture of stereocontrolled acetoxyazetidinone
US20090082571A1 (en) Intermediates of 2-substituted carbapenem derivatives and process for production thereof
KR20070102254A (en) Process for the preparation of carbapenem intermediates
ES2335889T3 (en) PROCESS FOR PREPARATION OF 2-DIAZO-3-TRIMETILSILILOXI-3-BUTENOIC ACID ESTERS.
HU192985B (en) Process for producing amino-/lower/-alkyl-penem-compounds
CN101367830B (en) Synthesis of sulfomycin derivant
KR100969217B1 (en) The preparaton of alkenylazetidinone intermediates for carbapenems
JPWO2004035539A1 (en) Process for producing carbapenems and intermediates used for the production
RU2086553C1 (en) Method for production of compounds of peneme and method for production of compound of azetidine-2-on
KR20040099963A (en) Chiral 2-azetidinone compounds, process and use thereof
KR101118145B1 (en) Process for preparing synthetic intermediates of penem or carbapenem antibiotics
KR101491868B1 (en) Method for producing 6-hydroxyethylpenam compound
JPH04368365A (en) Production of azetidinone derivative
JPH0931075A (en) Production of carbapenem intermediate
KR100201564B1 (en) Azetidinone compound and their preparation method
AT393839B (en) Stereocontrolled process for the preparation of novel penem compounds
RU2175971C2 (en) Method of preparing 2-halogenmethyl penems and 2-azitidinone derivatives as intermediate compounds
JPH0827168A (en) Carbapenem intermediate field
JPH061761A (en) Gamma,delta-unsaturated-beta-amino acid derivative and its production
KR20040006205A (en) Novel method for producing Aztreonam

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
NORF Unpaid initial registration fee